Trametinib effects and price

Trametinib is a targeted therapy drug mainly used to treat specific types of cancer, including malignant melanoma and non-small cell lung cancer. It belongs to the mitogen-activated protein kinase (MEK) inhibitor class of drugs. Trametinib blocks abnormal activation in cell signaling pathways by inhibiting the activity of MEK protein, thereby inhibiting the proliferation and growth of tumor cells. Trametinib has been launched in the domestic market and has been included in medical insurance. Patients can purchase it domestically at an approximate price of more than 10,000 yuan. The price is relatively high, but you need to consult the local hospital pharmacy for specific costs. In foreign countries, the price of trametinib is relatively low, mainly because there are many generic drugs to choose from, especially the generic drugs produced in Laos, which cost about one to two thousand yuan, which is much cheaper than in China. It should be noted that the ingredients of foreign generic drugs and domestic original drugs are basically the same.